Live Breaking News & Updates on Therapeutic Area Lead

Stay updated with breaking news from Therapeutic area lead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Phase 2 Data Demonstrate Potential Benefit of Nipocalimab for Pregnant Individuals at High Risk of Early-Onset Severe Haemolytic Disease of the Foetus and Newborn (HDFN)

New Phase 2 Data Demonstrate Potential Benefit of Nipocalimab for Pregnant Individuals at High Risk of Early-Onset Severe Haemolytic Disease of the Foetus and Newborn (HDFN)
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Ohio State University , Memorial Hermann Hospital , Region Flamande , Kennethj Moise Jr , Kenneth Moise , Katie Abouzahr , Moise Kj Jr , Hematology Am Soc Hematol Educ Program , Fetal Medicine Foundation World Congress , European Union , None Of The Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Drug Administration , Department Of Women Health , Exchange Commission , Janssen Pharmaceutical Companies , Momenta Pharmaceuticals Announces Fast Track Designation , Janssen Research Development , University Of Toronto Fetal Medicine , National Library Of Medicine , Fetal Center At Children Memorial Hermann Hospital , Companies Of Johnson , European Medicines Agency , Fetal Care Center , Comprehensive Fetal Care Center ,

Non-Invasive Approaches to NAFLD/NASH Drug Development, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) June 13, 2023 This webinar will focus on non-invasive approaches to NAFLD/NASH drug development. During the webinar, speakers will ....

United Kingdom , Vera Kovacevic , Katherinet Landschulz , Mohammad Shadab Siddiqui , Margerya Connelly , Honeycomb Worldwide Inc , Virginia Commonwealth University , Biomarker Solution Center , Drug Development , Strategic Director , Senior Director , Therapeutic Area Lead , Renal Disease , Neurodegenerative Diseases , Associate Professor , Non Invasive Approaches , Life Science ,

Transforming oncology with antibody therapeutics

Janssen EMEA Therapeutic Area Lead for Oncology discusses the potential of BsMAbs like amivantamab to address unmet needs in NSCLC treatment. ....

Byoung Chul , Martin Vogel , Janssen Europe , Personalized Medicine Coalition , European Lung Cancer Congress , Drug Administration , Therapeutic Area Lead , Therapeutic Area Lead Oncology , Epidermal Growth Factor Receptor , Mesenchymal Epithelial Transition Factor , Bispecific Antibody , Enable Multiple Mechanisms , Broad Clinical , Clinical Lung ,

Dalriada further strengthens small molecule discovery

TORONTO, April 19, 2023 (GLOBE NEWSWIRE) Dalriada, a leading Canadian contract research organization specializing in small molecule therapies,. ....

Diana Kraskouskaya , Dalriada Drug Discovery Inc , Thermo Fisher , Frosty Loechel , Discovery Strategy , Metabolic Diseases , Therapeutic Area Lead , Scientific Director , Chief Executive , Patrick Gunning , Chief Scientific Officer , Drug Discovery , Discovery Labs , Discovery Management , Key Opinion Leaders , Small Molecule , Drug Discovery ,

Time for Change in NASH: How Non-Invasive Biomarkers are Driving a Paradigm Shift in Clinical Trials and Clinical Care, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) October 12, 2022 Diagnosing and assessing the progression of nonalcoholic steatohepatitis (NASH) continue to be some of the most ....

United Kingdom , Margerya Connelly , Katherinet Landschulz , Claudia Filozof , Lara Dimick Santos , Vera Kovacevic , Labcorp Drug Development , Honeycomb Worldwide Inc , Biomarker Solution Center , Vice President , Liver Therapeutic Area , Senior Director , Therapeutic Area Lead , Executive Medical Director , Strategic Director , How Non Invasive Biomarkers , Paradigm Shift , Clinical Trials , Life Science , Press Release ,